{
  "trial_id": "NCT00404807",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "CHF subjects without obvious comorbidity",
      "label": "met",
      "evidence": "figure 1"
    },
    {
      "criterion": "AHI > 10 measured by conventional polysomnography",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "previous diagnosis of OSA or had been exposed to CPAP therapy",
      "label": "triggers"
    },
    {
      "criterion": "uncontrolled arterial hypertension",
      "label": "triggers"
    },
    {
      "criterion": "valvular or congenital cardiopathy, unstable angina, acute myocardial infarction or cardiac surgery in the three months prior to enrolment",
      "label": "triggers"
    }
  ],
  "notes": "Patient has multifactorial chronic hypoxemia and dyspnea thought due to diastolic CHF, pulmonary hypertension thought secondary to a chronic ASD and COPD on 5L home oxygen. Patient tolerated an inpatient sildenafil trial without hypotension.",
  "_meta": {
    "topic_id": "16",
    "trial_id": "NCT00404807",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}